ArticleNature reviews. Cardiology2014
Hypertension: How should data from SYMPLICITY HTN-3 be interpreted?
Article in Nature reviews. Cardiology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Renal denervation for hypertension.Nature reviews. Cardiology · 2025Review
- Acupuncture Attenuates Renal Sympathetic Activity and Blood Pressure via Beta-Adrenergic Receptors in Spontaneously Hypertensive Rats.Neural plasticity · 2017Article
- Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.Current hypertension reports · 2016Review
- Managing Treatment-Resistant Patients.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2015Review
- Beyond blood pressure: percutaneous renal denervation for the management of sympathetic hyperactivity and associated disease states.Journal of the American Heart Association · 2015Review
- Renal denervation for severe hypertension in a small child with Turner syndrome: miniaturisation of the procedure and results.BMJ case reports · 2015Article
- Renal sympathetic denervation after Symplicity HTN-3 and therapeutic drug monitoring in severe hypertension.Frontiers in physiology · 2015Review
- Renal Denervation After Symplicity HTN-3 - Back to Basics. Review of the Evidence.European cardiology · 2014Review
- Where and when device therapy may be useful in the management of drug-resistant hypertension.Current cardiology reports · 2014Review
- Ethnicity and sympathetic tone: predictors of the blood pressure response to renal denervation?Nature reviews. Cardiology · 2014Article
- Renal denervation--a valid treatment option despite SYMPLICITY HTN-3.Nature reviews. Cardiology · 2014Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
24839974What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.